A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2011
12/28/2011	CN102293820A 一种中药组合物在制备减少心肌梗死后患者死亡事件的药物中的应用 Chinese medicinal composition for the preparation of the drug in patients after myocardial infarction to reduce deaths Applications
12/28/2011	CN102293802A 一种治疗心血管疾病的药物组合物及其制备方法 A method of treating cardiovascular disease a pharmaceutical composition and its preparation method
12/28/2011	CN102293801A 一种川芎挥发油滴丸 One kind of volatile oil dropping pills
12/28/2011	CN102293800A 一种川芎挥发油软胶囊 One kind of volatile oil soft capsule
12/28/2011	CN102293794A 一种苏冰滴丸制剂及其制备 One kind of Su ice dripping pill and its preparation
12/28/2011	CN102293793A 一种水溶性银杏叶提取物的制备工艺 Preparation of a water-soluble extract of Ginkgo biloba
12/28/2011	CN102293791A 一种提取银杏叶有效成分的生产方法 A method for producing the active ingredients of Ginkgo biloba extract
12/28/2011	CN102293790A 高纯度银杏内酯组合物 High purity compositions Ginkgolides
12/28/2011	CN102293787A 灵芝的提取工艺 Extraction of Ganoderma
12/28/2011	CN102293784A 珍珠纳米硒及其制备方法 Pearl Nano-Se and its preparation method
12/28/2011	CN102293774A 前列腺素F2α衍生物的应用 Prostaglandin F2α derivatives
12/28/2011	CN102293773A 含有苯并硫氮杂卓和苯并虑平化合物的药物 Benzothiazepine and benzo drugs containing compounds doxepin
12/28/2011	CN102293767A 活性天然产物b用于制备抗血管性痴呆产品的用途 B active natural products used in the preparation of anti-vascular dementia uses of products
12/28/2011	CN102293763A 肾病和心脏病的治疗药物及其用途 Kidney disease and heart disease drugs and their uses
12/28/2011	CN102293762A 一种姜黄素衍生物在制备抗糖尿病及其并发症药物中的应用 One kind of curcumin derivatives in the preparation of anti-diabetes and its complications medicine
12/28/2011	CN102293760A 一种单硝酸异山梨酯择时控释制剂及其制备方法 When the controlled release formulation and preparation method isosorbide dinitrate selection
12/28/2011	CN102293753A 辅酶q10纳米混悬剂冻干组合物及其制备方法和应用 Coenzyme q10 nanosuspension lyophilized composition and preparation method and application
12/28/2011	CN102293744A 脑靶向丹参酮口服油包油纳米乳的组方及制备 Brain Tan prescription and preparation of oral targeted oil-oil nanoemulsion
12/28/2011	CN102293740A 一种藏红花酸注射剂及其制备方法 One kind of saffron acid injection and its preparation method
12/28/2011	CN102293734A 托伐普坦固体分散体及其制备方法 Tolvaptan solid dispersion and its preparation method
12/28/2011	CN102008676B 一种治疗脑性瘫痪的中药散剂 A method of treating cerebral palsy Chinese medicine powder
12/28/2011	CN101925572B 二氢化茚酰胺化合物制备方法、包含其的药物组合物、及其作为蛋白激酶抑制剂的应用 Indane amide compound preparation, pharmaceutical compositions containing them, their use as protein kinase inhibitors
12/28/2011	CN101897929B 改良的组合物及其制备方法和用途 Improved composition and its preparation method and use
12/28/2011	CN101869680B 滋肾益精、补脑安神的组合物的新用途 New uses Kidney essence, brain nerves composition
12/28/2011	CN101849968B 一种强肾胶囊药物及其制造方法 One kind of drug Qiangshen capsule and its manufacturing method
12/28/2011	CN101843765B 一种治疗肢体水肿的药物及其应用 A method of treating limb edema drugs and its application
12/28/2011	CN101810673B 铜污染土壤的海州香薷总黄酮提取物在制备血管扩张药物中的应用 Copper contaminated soil Elsholtzia splendens total flavonoid extract in the preparation of vasodilator drugs
12/28/2011	CN101732489B 一种治疗高血压的中草药 An herbal treatment of hypertension
12/28/2011	CN101703592B 一种治疗冠心病和心绞痛的药物及其制备方法 A coronary heart disease and angina drug treatment and its preparation method
12/28/2011	CN101679328B 老年黄斑变性的预防或治疗剂 Age-related macular degeneration prophylactic or therapeutic agent
12/28/2011	CN101653429B 一种从紫斑牡丹籽中提取α-亚麻酸制成软胶囊的方法 An extract from the seeds of Paeonia α- linolenic acid capsules made of soft methods
12/28/2011	CN101637448B 单硝酸异山梨酯液体制剂及其制备方法 Isosorbide dinitrate liquid and its preparation method
12/28/2011	CN101596240B 一种双丹微丸及其制备方法 A dual Dan pellets and its preparation method
12/28/2011	CN101531638B 用作雌激素相关受体调节剂的化合物及其应用 Compounds useful as modulators of estrogen-related receptor and Its Application
12/28/2011	CN101502541B 安息香属植物及其提取物的用途 Styrax uses of plants and their extracts
12/28/2011	CN101491550B 一种红曲提取物与辅酶q10复方制剂的制备方法 An extract of red yeast preparation thereof and coenzyme q10 compound preparation
12/28/2011	CN101455390B 一种具有调节血压功能的营养保健品及其制备方法 A function of regulating blood pressure nutraceuticals and preparation method
12/28/2011	CN101356980B 一种鱼肝脏水解物的制备方法及应用 A preparation method and application of fish liver hydrolyzate
12/28/2011	CN101336961B 冠心丹参滴丸及其制备方法 Coronary Danshen Diwan and its preparation method
12/28/2011	CN101336914B 一种缩小心肌梗死面积的药物组合物及其应用 Reduce myocardial infarct size of one kind of pharmaceutical compositions and applications
12/28/2011	CN101312973B 新的中氮茚衍生物，它们的制备方法和含有它们的药物组合物 New indolizine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/28/2011	CN101274012B 夏枯草属植物提取物的组合物、制备方法及其药物用途 Prunella plant extract composition, preparation and pharmaceutical use
12/28/2011	CN101247832B 含有血管紧张素Ⅱ受体拮抗剂和钙通道阻断剂的药物制剂 Containing an angiotensin Ⅱ receptor antagonists and calcium channel blockers in pharmaceutical formulations
12/28/2011	CN101180046B 含有屈昔多巴的稳定片剂 Containing droxidopa stable tablet
12/28/2011	CN101085296B 一种冻干粉针剂及其制备方法 A lyophilized powder for injection and its preparation method
12/28/2011	CN101036646B 苦木总生物碱及其单体生物碱的医药用途 Wood bitter alkaloid monomers total alkaloids and medicinal use
12/28/2011	CN101011522B 一种治疗心脏病的中药制剂 Chinese medicine a treatment for heart disease
12/28/2011	CN101007000B 异黄酮化合物的制药用途以及含有它们的组合物 Isoflavone compounds and pharmaceutical use of the compositions containing them
12/27/2011	US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011	US8084591 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders
12/27/2011	US8084578 Monoclonal antibody against human scavenger receptor SRCL-P1
12/27/2011	US8084415 Uteroglobin in the treatment of IGA mediated nephropathy
12/27/2011	US8084413 Urocortin-III and uses thereof
12/27/2011	US8084031 Method for the treatment of inflammatory disorders
12/22/2011	WO2011159980A1 Anti-axl antibodies and methods of use
12/22/2011	WO2011159839A2 Thioacetate compounds, compositions and methods of use
12/22/2011	WO2011159706A1 Ranolazine for use for the treatment of pulmonary hypertension
12/22/2011	WO2011159693A2 Oral treatment of digital ischemic lesions
12/22/2011	WO2011158880A1 Crystal of amide compound
12/22/2011	WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue
12/22/2011	WO2011158053A1 Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them
12/22/2011	WO2011158050A1 Process for the preparation of dronedarone
12/22/2011	WO2011157908A1 Use of the combination of an inhibitor of the if current of the sinoatrial node and an inhibitor of the angiotensin-converting enzyme for treating heart failure
12/22/2011	WO2011157059A1 Use of isoacteoside or pharmaceutically acceptable saltthereof
12/22/2011	WO2011157029A1 Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
12/22/2011	WO2011100659A3 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
12/22/2011	WO2010139967A8 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
12/22/2011	US20110313055 Health characteristic chewy or gummy candy confection
12/22/2011	US20110313042 Amino Acid Compositions
12/22/2011	US20110313041 Food supplements on the basis of pantothenic acid
12/22/2011	US20110313033 Ophthalmic uses of s1p receptor modulators
12/22/2011	US20110313024 RNA INTERFERENCE MEDIATED INHIBITION OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/22/2011	US20110313020 UsiRNA Complexes
12/22/2011	US20110313012 Amino Acid Compounds
12/22/2011	US20110313006 PHARMACEUTICAL COMPOSITION OF LEVAMLODIPINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND β RECEPTOR BLOCKING AGENT, AND USE THEREOF
12/22/2011	US20110313004 Deuterated pyridinones
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011	US20110312991 Activated blood coagulation factor inhibitor
12/22/2011	US20110312990 Diamine Derivatives
12/22/2011	US20110312989 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
12/22/2011	US20110312979 Fused pyrrole derivatives as pi3k inhibitors
12/22/2011	US20110312974 Heteroaryl antagonists of prostaglandin d2 receptors
12/22/2011	US20110312971 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/22/2011	US20110312970 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
12/22/2011	US20110312965 Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
12/22/2011	US20110312964 Cysteine protease inhibitors
12/22/2011	US20110312960 Pyrazine derivatives and use as pi3k inhibitors
12/22/2011	US20110312956 ARYLINDENOPYRIMIDINES WITH REDUCED hERG CHANNEL BINDING
12/22/2011	US20110312954 Mineralocorticoid receptor antagonist and methods of use
12/22/2011	US20110312951 C-Ring Modified Tricyclic Benzonaphthiridinone Protein Kinase Inhibitors and Use Thereof
12/22/2011	US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312941 1,4-disubstituted piperidines as vasopressin receptor via antagonists
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312930 Aryl compounds with aminoalkyl substituents and their use
12/22/2011	US20110312922 EDTA Resistant S100A12 Complexes (ERAC)
12/22/2011	US20110312920 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
12/22/2011	US20110312905 Stimulus-triggered prodrugs
12/22/2011	US20110312901 Methods of inhibiting cell death or inflammation in a mammal by administering a bcl protein

1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 1595